Ignite Creation Date:
2025-12-24 @ 5:34 PM
Ignite Modification Date:
2026-01-21 @ 3:36 PM
Study NCT ID:
NCT02505568
Status:
COMPLETED
Last Update Posted:
2019-10-17
First Post:
2015-06-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate Efficacy and Safety of Infliximab in Participant With Moderate-to-Severe Refractory Intestinal Behcet's Disease
Sponsor:
Janssen Korea, Ltd., Korea
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-07-22
Start Date Type:
ACTUAL
Primary Completion Date:
2018-07-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-07-13
Completion Date Type:
ACTUAL
First Submit Date:
2015-06-29
First Submit QC Date:
None
Study First Post Date:
2015-07-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-10-16
Last Update Post Date:
2019-10-17
Last Update Post Date Type:
ACTUAL